Rentech Nitrogen Partners, L.P. (NYSE:RNF) [Trend Analysis] finished at $13.25 as shares increasing 28.64%. Rentech Nitrogen Partners to merge with CVR Partners. CVR Partners (UAN) and Rentech Nitrogen Partners (RNF) reported that execution of a definitive merger contract under which CVR Partners will attain all outstanding units of Rentech Nitrogen. The combination excludes Rentech Nitrogen’s Pasadena facility, which will be retained by current holders of Rentech Nitrogen, or sold separately for their benefit. Total consideration for Rentech Nitrogen not comprising the Pasadena facility is $533 million, implying a total enterprise value of about $839 million, based on closing prices on August 7, 2015. The transaction is the culmination of a planned review process publicly reported by Rentech Nitrogen on February 17, 2015. As took noticed on the firm performance, its weekly performance was 15.12%, monthly performance was -5.83%.
Rentech Nitrogen Partners L.P. (NYSE:RNF) is currently trading at $13.72. Rentech Nitrogen Partners, L.P. (RNP) is a master limited partnership that owns and operates its fertilizer business. The Company operates through two business segments: East Dubuque and Pasadena. The Company’s East Dubuque segment includes the operations of the East Dubuque Facility, which produces ammonia, ammonium nitrate solution (UAN), liquid and granular urea, nitric acid and food-grade carbon dioxide (CO2), using natural gas as its primary feedstock. The East Dubuque Facility is located in the center of the Mid Corn Belt, which includes the States of Illinois, Indiana, Iowa, Missouri, Nebraska and Ohio. The Company’s Pasadena segment includes the operations of the Pasadena Facility, which produces synthetic ammonium sulfate, ammonium sulfate, sulfuric acid and ammonium thiosulfate, using ammonia and sulfur as the facility’s primary feedstock. The Pasadena Facility is located on an 85-acre site located on the Houston Ship Channel.
Pfizer Inc. (NYSE:PFE) [Trend Analysis] stock finished trading at $35.32 in last trading day with market capitalization of 217830.80 million. Pfizer reported authorization from the Canadian Competition Bureau, with respect to its pending acquisition of Hospira.
Pfizer Inc. (NYSE:PFE) is currently trading at $33.55. Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. It operates in three segments: Global Innovative Pharmaceutical segment (GIP), Global Vaccines, Oncology and Consumer Healthcare segment (VOC) and Global Established Pharmaceutical segment (GEP). GIP is focused on developing, registering and commercializing medications in therapeutic areas, such as inflammation, cardiovascular/metabolic, neuroscience and pain, rare diseases and women’s/men’s health. VOC focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. GEP includes its sterile injectable products and bio similar development portfolio.
Law office of Brodsky & Smith, LLC declared that it is investigating possible claims against the BOD of Sapient Corp. (NASDAQ:SAPE) [Trend Analysis] relating to the offered acquisition by Publicis Groupe S.A. Sapient Corp. (NASDAQ:SAPE) moved up 0.12% in last regular trading with 8.35 Million trading volume.
Sapient Corp. (NASDAQ:SAPE) is currently trading at $24.98. Sapient Corporation (Sapient) is a global services company, which helps clients leverage marketing and technology to transform their businesses. The Company operates in three business units: SapientNitro, Sapient Global Markets, and Sapient Government Services. SapientNitro provides integrated marketing and creative services, Web and interactive development, advertising, media planning and buying, strategic planning and marketing analytics, multi-channel commerce strategy and solutions, including a focus on mobile, and content and asset management strategies and solutions. Through this business unit, it combines multi-channel marketing and commerce. Sapient Global Markets provides integrated advisory, program management, analytics, technology and operations services to capital and commodity markets. Sapient Government Services provides consulting, technology, and marketing services to the United States government agencies and non-governmental organizations (NGOs).